Dose-finding study of cilazapril (inhibace® in patients with uncomplicated essential hypertension

Clinical and Experimental Hypertension

Volumn A13, Issue 8, 1991, Pages 1415-1432

  Mroczek, William J ^a   Klein, Jonathan ^a,b   Burris, James F ^a  

^a Cardiovascular Center of Northern Virginia ^*  (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ACE inhibitor; Cilazapril; Hypertension therapy; Once daily therapy

Indexed keywords

CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CILAZAPRIL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGE; PYRIDAZINES;

EID: 0026009155     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969109048802     Document Type: Article

References (6)

1. The 1988 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure�
2. The Pharmacodynamics and Dose-Response Relationships of the Angiotensin Converting Enzyme Inhibitor Cilazapril in Essential Hypertension�
3. Cardiovascular Effects of the New Angiotensin-Converting-Enzyme Inhibitor, Cilazapril, in Anesthetized and Conscious Dogs�
4. Enzyme Immunoassay Discrimination of a New Angiotensin-Converting Enzyme (ACE) Inhibitor, Cilazapril, and Its Active Metabolite�
5. Biological Properties of the Angiotensin-Converting Enzyme Inhibitor Cilazapril�
6. Effects of Single Doses of the Converting Enzyme Inhibitor Cilazapril in Normal Volunteers�